Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Advanced Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.
Advanced Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
Market Analysis and Insights: Global Advanced Wound Care Biologics Market
Due to the COVID-19 pandemic, the global Advanced Wound Care Biologics market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Biologic Skin Substitutes accounting for % of the Advanced Wound Care Biologics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Acute Wounds segment is altered to an % CAGR throughout this forecast period.
China Advanced Wound Care Biologics market size is valued at US$ million in 2021, while the US and Europe Advanced Wound Care Biologics are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Advanced Wound Care Biologics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Advanced Wound Care Biologics include Alphatec Spine,Inc., Amnio Technology, LLC, Derma Sciences, Integra, Medline, MiMedx, Organogenesis, Osiris and Pinnacle Transplant Technologies, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Advanced Wound Care Biologics Scope and Segment
Advanced Wound Care Biologics market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Advanced Wound Care Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Biologic Skin Substitutes
Enzyme Based Formulations
Growth Factors
Segment by Application
Acute Wounds
Chronic Wounds
Surgical Wounds
By Company
Alphatec Spine,Inc.
Amnio Technology, LLC
Derma Sciences
Integra
Medline
MiMedx
Organogenesis
Osiris
Pinnacle Transplant Technologies
Skye Biologics
Smith & Nephew
Soluble Systems
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Advanced Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.
Market Analysis and Insights: Global Advanced Wound Care Biologics Market
Due to the COVID-19 pandemic, the global Advanced Wound Care Biologics market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Biologic Skin Substitutes accounting for % of the Advanced Wound Care Biologics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Acute Wounds segment is altered to an % CAGR throughout this forecast period.
China Advanced Wound Care Biologics market size is valued at US$ million in 2021, while the US and Europe Advanced Wound Care Biologics are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Advanced Wound Care Biologics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Advanced Wound Care Biologics include Alphatec Spine,Inc., Amnio Technology, LLC, Derma Sciences, Integra, Medline, MiMedx, Organogenesis, Osiris and Pinnacle Transplant Technologies, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Advanced Wound Care Biologics Scope and Segment
Advanced Wound Care Biologics market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Advanced Wound Care Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Biologic Skin Substitutes
Enzyme Based Formulations
Growth Factors
Segment by Application
Acute Wounds
Chronic Wounds
Surgical Wounds
By Company
Alphatec Spine,Inc.
Amnio Technology, LLC
Derma Sciences
Integra
Medline
MiMedx
Organogenesis
Osiris
Pinnacle Transplant Technologies
Skye Biologics
Smith & Nephew
Soluble Systems
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
